Wells Fargo Lowers Clorox Price Target Amid 2026 Projections

The Clorox Company (NYSE:CLX) saw its price target reduced by Wells Fargo on January 5, 2026, following an update to the bank’s financial models related to the consumer staples sector. The new target is set at $108, down from the previous $117. Despite this adjustment, Wells Fargo has retained an Equal Weight rating on the stock, indicating a neutral stance on its performance.

Wells Fargo’s decision comes as the bank revises its projections across various segments, including Beverage, Food, and Home and Personal Care. This update reflects a broader assessment of the market landscape, particularly as the company prepares for the upcoming fiscal year.

In November, Clorox reported a stronger-than-expected first quarter. The company achieved adjusted earnings of $0.85 per share, surpassing analyst estimates of $0.79, according to data from LSEG. Despite a 19% decline in revenue, which totaled $1.43 billion, the results exceeded expectations of $1.40 billion. Management had already indicated that lower shipments were anticipated due to retailers pulling forward inventory in preparation for a system upgrade.

Looking ahead, Clorox maintains its outlook for the full year, expecting sales to decline between 6% and 10%. Adjusted earnings are projected to fall between $5.95 and $6.30 per share. The company’s dividend payout ratio is currently around 72% of next year’s earnings estimates, a figure deemed manageable by analysts, thanks to a robust balance sheet.

Clorox aims for annual sales growth of 3% to 5%, which should support stable dividend growth for the company, known for its high return on invested capital (ROIC). As a multinational manufacturer and marketer of consumer and professional products, Clorox remains a significant player in the consumer goods industry.

While there is potential in Clorox as an investment, some analysts express stronger confidence in artificial intelligence stocks, which they believe may offer higher returns with less risk. Investors looking for promising opportunities are encouraged to explore options beyond Clorox, as the market continues to evolve.

Overall, Clorox’s position in the consumer staples sector remains solid, with its commitment to dividend distribution and growth strategies offering a level of stability for investors.